Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer’s Disease and Other Tauopathies. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.